MedPlus Health Services Limited (BOM:543427)

MedPlus Health Services Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 20, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	82,839	100,834	90,967	82,223	77,513	121,036
Market Cap Growth	-16.70%	10.85%	10.63%	6.08%	-35.96%	-
Enterprise Value	90,946	106,712	98,583	89,837	81,173	126,771
Last Close Price	688.40	837.75	759.55	689.45	651.15	1010.25

Price Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 20, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	39.36	45.92	60.55	125.58	155.76	126.34
PS Ratio	1.15	1.46	1.48	1.46	1.70	3.20
PB Ratio	4.20	5.11	5.23	5.21	5.20	8.54
P/TBV Ratio	4.30	5.24	5.38	5.39	5.38	8.83
P/FCF Ratio	22.24	27.07	18.91	138.57	-	232.01
P/OCF Ratio	16.72	20.35	16.83	57.20	85.74	71.24

EV Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 20, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
EV/Sales Ratio	1.26	1.55	1.61	1.60	1.78	3.35
EV/EBITDA Ratio	15.19	25.58	30.44	43.10	57.51	67.89
EV/EBIT Ratio	28.90	31.22	39.40	63.15	84.48	77.91
EV/FCF Ratio	24.41	28.64	20.50	151.40	-	243.01

Financial Efficiency

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 20, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Debt / Equity Ratio	0.72	0.72	0.64	0.64	0.60	0.57
Debt / EBITDA Ratio	2.38	2.29	2.26	2.77	3.26	2.90
Debt / FCF Ratio	-	3.82	2.33	17.01	-	15.62
Net Debt / Equity Ratio	0.41	0.42	0.39	0.54	0.45	0.56
Net Debt / EBITDA Ratio	2.05	2.00	2.10	4.05	4.76	4.25
Net Debt / FCF Ratio	-	2.23	1.41	14.23	-8.54	15.21
Asset Turnover	-	1.89	1.93	1.94	1.69	1.82
Inventory Turnover	-	3.75	3.48	3.55	3.47	3.60
Quick Ratio	-	0.93	0.80	0.36	0.51	0.10
Current Ratio	-	3.00	3.20	2.98	3.11	2.92
Return on Equity (ROE)	-	11.82%	9.05%	4.28%	3.45%	8.82%
Return on Assets (ROA)	-	5.86%	4.91%	3.06%	2.23%	4.89%
Return on Invested Capital (ROIC)	8.96%	10.43%	8.47%	5.54%	4.40%	7.63%
Return on Capital Employed (ROCE)	-	10.50%	9.00%	5.70%	4.10%	8.00%

Yields

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 20, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Earnings Yield	2.54%	2.18%	1.65%	0.80%	0.64%	0.79%
FCF Yield	4.50%	3.69%	5.29%	0.72%	-1.01%	0.43%
Buyback Yield / Dilution	-0.00%	-0.06%	0.00%	-0.31%	-6.38%	-3.82%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 22, 2026

Data Sources Report a data error